-
Taxonomy & unit
-
ratio: %
-
Description
-
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
-
Summary
-
Estrella Immunopharma, Inc. quarterly Debt-to-equity history and change rate from Q2 2022 to Q3 2025.
- Estrella Immunopharma, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -168 %, a 1126% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)